Glipizide EP Impurity A

Glipizide EP Impurity A is a structurally related byproduct arising from the synthetic pathway of glipizide, characterized by a substituted pyridine ring linked to a sulfonylurea moiety. It features a cyclohexylmethyl group at the 3-position of the pyridine core, with a methoxyimino substituent on the sulfonylurea bridge, distinguishing it from the parent drug's ethoxyimino group. This impurity retains the critical pharmacophoric elements of glipizide but exhibits altered steric hindrance due to the methoxyimino substitution. It serves as a reference standard for HPLC-based quantification of process-related impurities in glipizide active pharmaceutical ingredient (API) batches.